Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06117865

Digital Treatment of Irritable Bowel Syndrome (IBS)

A Randomized Controlled Digital Intervention Study to Assess the Effect of Internet Delivered Interventions, the Low FODMAP-diet, Behavioral Therapy or Both, Compared to Patient Education, on Measures of Gastrointestinal Symptom Relief and Quality of Life in Patients With Irritable Bowel Syndrome

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
728 (estimated)
Sponsor
Haukeland University Hospital · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The aim of this work is to identify whether the digital treatment program Mage-tarmskolen has an effect on patients with IBS. Our secondary objectives is to address multiple aspects of digital treatmtent success of the different modules. The patients will be randomized to one of four arms and will be delivered different kinds of digital treatment. All patients will have access to ask questions to a registered dietitian. Primary end point is the proportion of patients with treatment success in the low FODMAP, behavioral therapy or both groups, versus the patient education group (sham). Treatment effect is defined as an improvement of 50 points or more on the IBS severity scoring system at 3 months after treatment start compared to the score before treatment.

Conditions

Interventions

TypeNameDescription
BEHAVIORALModule 1Module 1: Introduction to IBS by a gastroenterologist.
BEHAVIORALModule 2Module 2:Introduction to pain physiology and how the nervous system works by a physiotherapist including practical exercises.
BEHAVIORALModule 3Module 3: Evidence-based guidelines for diet and lifestyle advice (NICE Guidelines) by a clinical dietitian.
BEHAVIORALModule 4Module 4: Intervention: behavioral therapy (exposure therapy and cognitive behavioral therapy).
BEHAVIORALModule 5Module 5: Intervention: The low FODMAP diet.

Timeline

Start date
2023-12-01
Primary completion
2025-02-28
Completion
2033-12-31
First posted
2023-11-07
Last updated
2025-05-16

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT06117865. Inclusion in this directory is not an endorsement.